Agnirva Space Premier League - Expedition #30946: Keeping Astronauts Healthy: Testing Blood Cell Technology in Space

Health monitoring in space is no simple task, especially when access to medical equipment is limited. That’s where the "HemoCue WBC DIFF White Blood Cell Count and Differentiator Technology Demonstration" comes in. This experiment, part of NASA's Human Research Program, tested a compact device that allows astronauts to analyze their white blood cell count and types directly aboard the ISS.

Led by Kimesha Calaway and developed in collaboration with NASA’s Johnson and Glenn Research Centers, the HemoCue WBC DIFF device is a small, handheld analyzer that can provide accurate blood diagnostics quickly and efficiently. It works by drawing a tiny blood sample and using advanced optics and imaging to identify and count different white blood cells.

Why is this important? White blood cells are a crucial indicator of immune health. Space travel is known to affect the immune system, making astronauts more susceptible to illness. With a reliable tool like this onboard, astronauts can monitor their immune status in real time and take preventive actions if needed.

During Expeditions 64 and 65, astronauts used this technology to test its performance under microgravity conditions. The data collected is helping scientists assess whether such compact diagnostic tools can become standard for long-duration space missions—and even for remote healthcare applications on Earth.

Beyond space, this technology could transform medical care in rural areas or during emergencies where traditional lab facilities aren’t available.

Join the Agnirva Space Internship Program

Get certified with over 100 hours of immersive, self-paced learning in astronomy, cosmology, space technology, and climate science through the Agnirva Space Internship Program. Join, complete virtual projects, and earn a digital certificate to showcase your space fluency in interviews, resumes, and beyond.